Prognostic significance of prolactin receptors in human breast cancer.

Jacques Bonneterre(Université Lille Nord de France), A Demaille(Centre Oscar Lambret), R. Beuscart, Jean Louis Lefèbvre(Centre Oscar Lambret), J.P. Peyrat

PubMed

September 1, 1987

Cited by 43

Related Papers

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

|Head & Neck|2005|1.8k

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

|Journal of Clinical Oncology|2000|840

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

|Journal of Clinical Oncology|2013|418

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

|JNCI Journal of the National Cancer Institute|2009|282

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma

|British Journal of Cancer|2000|253